Target intelligence / Profile preview

Natural killer cell and dendritic cell interface (NK-DC interface)

Target
NK-DC interface
Molecular classification
Cell-cell interaction, Immune synapse
01

Overview

The Natural killer (NK) cell and dendritic cell (DC) interface represents a complex bidirectional crosstalk essential for the coordination of innate and adaptive immune responses (Degli-Esposti & Smyth, 2005, Nature Reviews Immunology). This interaction occurs primarily in secondary lymphoid organs and peripheral tissues, where DCs activate NK cells through the secretion of cytokines such as IL-12, IL-15, and IL-18, and through direct contact via surface molecules (Ferlazzo & Morandi, 2014, Frontiers in Immunology). Conversely, NK cells promote DC maturation and Th1 polarization by producing interferon-gamma (IFN-γ) and tumor necrosis factor (TNF). A unique aspect of this interface is "DC editing," where NK cells selectively eliminate immature DCs via the NKp30 receptor to ensure only high-quality antigen-presenting cells initiate T-cell responses (Pallmer & Oxenius, 2016, Frontiers in Immunology). Dysregulation of this interface is implicated in cancer progression, where the crosstalk is often suppressed, and in autoimmune diseases where it may be overactive. Therapeutic strategies aim to harness this interface by using recombinant cytokines or monoclonal antibodies to enhance the anti-tumor activity of the NK-DC axis (Ferlazzo & Morandi, 2014, Frontiers in Immunology).

Other names
NK-DC crosstalkNK-DC interactionNK-DC synapseNatural killer cell-dendritic cell axis
02

Mechanism of action

Modulation of bidirectional signaling between NK cells and DCs to enhance immune surveillance and effector function.

03

Biological functions

Immune responseCytokine productionAntigen presentationCell activationTh1 polarizationDendritic cell maturation
04

Disease associations

CancerInfectionAutoimmune diseaseInflammation
05

Safety considerations

Cytokine release syndromeAutoimmunitySystemic inflammationOff-target immune activation
06

Interacting drugs

Interleukin-12

5 more in the full profile.

07

Biomarkers

Interferon-gammaInterleukin-12CD69 (NK activation marker)CD80/CD86 (DC maturation markers)HLA-DR expression

Beyond the preview

Go deeper on Natural killer cell and dendritic cell interface (NK-DC interface).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Natural killer cell and dendritic cell interface (NK-DC interface).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call